P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 209 500 KRW -4.34% Market Closed
Market Cap: 2.2T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

PharmaResearch Co Ltd
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PharmaResearch Co Ltd
Research & Development Peer Comparison

Comparables:
068270
302440
H
145020
196170
A
298380

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
P
PharmaResearch Co Ltd
KOSDAQ:214450
Research & Development
-â‚©17.7B
CAGR 3-Years
-38%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
SK Bioscience Co Ltd
KRX:302440
Research & Development
-â‚©85.7B
CAGR 3-Years
-52%
CAGR 5-Years
-52%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Research & Development
-â‚©8.9B
CAGR 3-Years
14%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Research & Development
-â‚©28.6B
CAGR 3-Years
-23%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
A
ABL Bio Inc
KOSDAQ:298380
Research & Development
-â‚©45.9B
CAGR 3-Years
2%
CAGR 5-Years
-36%
CAGR 10-Years
N/A

See Also

What is PharmaResearch Co Ltd's Research & Development?
Research & Development
-17.7B KRW

Based on the financial report for Jun 30, 2024, PharmaResearch Co Ltd's Research & Development amounts to -17.7B KRW.

What is PharmaResearch Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-32%

Over the last year, the Research & Development growth was -54%. The average annual Research & Development growth rates for PharmaResearch Co Ltd have been -38% over the past three years , -32% over the past five years .

Back to Top